Bradykinin is a potent vasodilator peptide that regulates inflammation, vascular and renal functions, and neural activities; it promotes invasion and migration of colorectal cancer cells; stimulates ERK1/2 activation and IL-6 production; inhibits tissue factor (TF) expression induced by LPS in a dose-dependent manner; improves pancreatic microcirculation and hemorheology in rats with severe acute pancreatitis; reduces thrombus formation in vivo; and exerts its effects primarily through activation of endothelial B2 receptors, leading to the release of prostacyclin, nitric oxide (NO), and endothelium-derived hyperpolarizing factor (EDHF).